Yahoo! Groups Tips
Did you know...
Hear how Yahoo! Groups has changed the lives of others. Take me there.
|
| Fw: Symposium Update: New Speakers, Extended Deadline |
Message List
|
----- Original Message -----
Sent: Thursday, June 05, 2003 10:54 PM
Subject: Symposium Update: New Speakers, Extended Deadline
Montréal, August 16th - 19th, 2003
At this expert assembly, clinical and basic investigators will survey the breakthroughs in science and technology that are impacting on emerging dimensions of cancer control.
Associate your research with this outstanding program. The deadline for submission of abstracts has been extended to June 16th.
If you have already submitted your work and are awaiting confirmation of your scheduling in the final program, please expect to receive notification promptly following the new deadline.
Meeting Website: http://www.cancerprev.org/Meetings/2003/
Main themes of the symposium:
- molecular biology
- environmental multifactorial effects
- precursor identification
- predictive markers
- prevention research
- screening
- intervention strategies
Plenary Program:
(See the website for the current plenary program.)
Day 1: Cancer Biology
- Morning Plenary Session: Genomics & Proteomics
- Keynote: Diet influence in oncogenesis & therapy
- Afternoon Plenary Session: Chronic Inflammation
Day 2: Cancer Prevention
- Morning Plenary Session: Strategies
- Keynote: National Cancer Control Programs: best way to reduce cancer burden
- Afternoon Plenary Session: Risk Avoidance & Reduction
Day 3: Cancer Screening
- Morning Plenary Session: Challenges
- Keynote: Cancer prevention research & cancer control strategies
- Afternoon Plenary Session: Controversies
Day 4: Cancer Intervention
- Morning Plenary Session: Strategies
- Keynote: Translational Research
- Afternoon Plenary Session: Therapies
Invited Faculty: (partial listing)
- Pierre R. Band, MD PhD (Health Protection Branch, Health Canada)
- Helmut Bartsch, PhD (DKFZ Heidelberg)
- William T Beck, PhD (University of Illinois, Chicago)
- Ricardo Brentani, PhD (Ludwig Institute for Cancer Research, Sao Paulo)
- Lukas Bubendorf, MD (Institute of Pathology, Basle)
- A Casson MD (Dalnousie, Halifax)
- Angus G Dalgleish, MD (St George's Hospital, London)
- Guy de Thé, MD PhD (Institut Pasteur, Paris)
- Eduardo L Franco, PhD DPH (McGill University)
- Hirota Fujiki, MD (Tokushima Bunri University)
- A-NT Kong, PhD (EOHSI, Rutgers - University New Jersey)
- D Krewski PhD (Institute of Population Health, Ottawa)
- Parviz Ghadirian, PhD (CHUM, Montréal)
- William C Hahn, MD PhD (Harvard Medical School)
- Susumu Ikehara, MD PhD (Kansai Medical University)
- Ron Lieberman, MD (National Cancer Institute, Bethesda)
- Henry T Lynch, MD (Hereditary Cancer Institute)
- Anthony B Miller, MB Bchir (DKFZ, Heidelberg)
- Alfred I Neugut, MD (Columbia University, New York)
- Frank J Rauscher III, PhD (Wistar Institute, Philadelphia)
- Jeffrey Schlom, PhD (Center for Cancer Research, National C ancer Institute)
- Cecilia Sepulveda, MD (WHO, Cancer Control Program)
- Zongtang Sun, MD (National Lab Molecular Oncology, Beijing)
- Terrence Sullivan, MD (Canadian Strategy for Cancer Control)
- Simon Sutcliffe, MD (University of British Columbia)
- Rachel F Tyndale (University of Toronto)
- Harry U Vainio, MD (International Agency for Research on Cancer, Lyon)
- Th Van der Kwast, MD (Erasmus University, Rotterdam)
- John Weisburger MD PhD (American Health Foundation, New York)
Sponsors
Partial funding for the meeting has been awarded by the CIHR and the ISPO. See the website for the complete list of sponsors & organizers.
Meeting Website: http://www.cancerprev.org/Meetings/2003/ -- Herbert E. Nieburgs, MD
Editor-in-Chief, Cancer Detection and Prevention
Professor of Pathology, University of Massachusetts Medical School
tel: +1 508 856 1822 fax: +1 508 856 1824
http://www.cancerprev.org/ISPO/Contact/
|
Joseph Eldor <a1b2c3d4@...>
csen_interna...
 Offline
 Send Email
|
Montréal, August 16th -
19th, 2003 At this expert assembly, clinical and basic investigators will
survey the breakthroughs in science and technology that are
impacting on emerging dimensions of cancer control. Associate your research with this outstanding program.
The deadline for submission of abstracts has been extended
to June 16th. If you have already submitted your work and are awaiting
confirmation of your scheduling in the final program, please expect
to receive notification promptly following the new deadline. Meeting Website: http://www.cancerprev.org/Meetings/2003/ Main themes of the symposium:- molecular biology
- environmental multifactorial effects
- precursor identification
- predictive markers
- prevention research
- screening
- intervention strategies
Plenary Program:(See the website for the current
plenary program.) Day 1:
Cancer Biology- Morning Plenary Session:
Genomics & Proteomics
- Keynote:
Diet influence in oncogenesis & therapy
- Afternoon Plenary Session:
Chronic Inflammation
Day 2:
Cancer Prevention- Morning Plenary Session:
Strategies
- Keynote:
National Cancer Control Programs: best way to reduce cancer
burden
- Afternoon Plenary Session:
Risk Avoidance & Reduction
Day 3:
Cancer Screening- Morning Plenary Session:
Challenges
- Keynote:
Cancer prevention research & cancer control strategies
- Afternoon Plenary Session:
Controversies
Day 4:
Cancer Intervention- Morning Plenary Session:
Strategies
- Keynote:
Translational Research
- Afternoon Plenary Session:
Therapies
Invited Faculty: (partial listing)- Pierre R. Band, MD PhD (Health Protection Branch, Health
Canada)
- Helmut Bartsch, PhD (DKFZ Heidelberg)
- William T Beck, PhD (University of Illinois, Chicago)
- Ricardo Brentani, PhD (Ludwig Institute for Cancer Research,
Sao Paulo)
- Lukas Bubendorf, MD (Institute of Pathology, Basle)
- A Casson MD (Dalnousie, Halifax)
- Angus G Dalgleish, MD (St George's Hospital, London)
- Guy de Thé, MD PhD (Institut Pasteur, Paris)
- Eduardo L Franco, PhD DPH (McGill University)
- Hirota Fujiki, MD (Tokushima Bunri University)
- A-NT Kong, PhD (EOHSI, Rutgers - University New Jersey)
- D Krewski PhD (Institute of Population Health, Ottawa)
- Parviz Ghadirian, PhD (CHUM, Montréal)
- William C Hahn, MD PhD (Harvard Medical School)
- Susumu Ikehara, MD PhD (Kansai Medical University)
- Ron Lieberman, MD (National Cancer Institute, Bethesda)
- Henry T Lynch, MD (Hereditary Cancer Institute)
- Anthony B Miller, MB Bchir (DKFZ, Heidelberg)
- Alfred I Neugut, MD (Columbia University, New York)
- Frank J Rauscher III, PhD (Wistar Institute, Philadelphia)
- Jeffrey Schlom, PhD (Center for Cancer Research, National C
ancer
Institute)
- Cecilia Sepulveda, MD (WHO, Cancer Control Program)
- Zongtang Sun, MD (National Lab Molecular Oncology, Beijing)
- Terrence Sullivan, MD (Canadian Strategy for Cancer
Control)
- Simon Sutcliffe, MD (University of British Columbia)
- Rachel F Tyndale (University of Toronto)
- Harry U Vainio, MD (International Agency for Research on Cancer,
Lyon)
- Th Van der Kwast, MD (Erasmus University, Rotterdam)
- John Weisburger MD PhD (American Health Foundation, New York)
SponsorsPartial funding for the meeting has been awarded by the CIHR and the
ISPO.
See the website for the complete list of
sponsors & organizers. Meeting Website: http://www.cancerprev.org/Meetings/2003/ --
Herbert E. Nieburgs, MD
Editor-in-Chief, Cancer Detection and Prevention
Professor of Pathology, University of Massachusetts Medical School
tel: +1 508 856 1822 fax: +1 508 856 1824
http://www.cancerprev.org/ISPO/Contact/
|
|
Having problems with message search?
